According to the TCGA and Gene Expression Omnibus (GEO) databases, we also found that SIRT1 overexpression was correlated to better prognosis in human patients with cancers that frequently carry oncogenic RAS mutations (Figure 1 and Figure S1). Here, SIRT1 is linked to cancer.